Ephedra Supplement Safety To Be Revisited At Senate Subcommittee Hearing
This article was originally published in The Tan Sheet
An "independent analysis" of 14,700 ephedra-related adverse event reports received by Metabolife International will be discussed by the Senate Governmental Affairs/Oversight of Government Management Subcommittee during a hearing slated for Oct. 8
You may also be interested in...
An FDA task force will review the 13,000 ephedrine alkaloid patient complaint records Metabolife is releasing in response to publicity surrounding a criminal investigation into whether the company lied about its knowledge of adverse events
Sen. Dick Durbin (D-Ill.) is pressing HHS Secretary Tommy Thompson to take immediate action against the sale of ephedra weight-loss dietary supplements by declaring the herbal ingredient an "imminent hazard.
Sen. Dick Durbin (D-Ill.) is exploring the concept of a new regulatory scheme for dietary supplements that would create a separate regulatory category for herbal products